Most important, with ALT often being normal in several cases of chronic hepatitis, especially in cases with major fibrosis, the DOC biomarker may prove be of significant clinical value as an additional biomarker together with ALT, and should thus be further evaluated for use in monitoring of such patients. This evidence concerns the gene GPT and chronic hepatitis.